查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1864512

拋棄式產品市場（按產品類型、應用、最終用戶、血液成分、材料和銷售管道分類）－2025-2032年全球預測

Blood Processing Disposables Market by Product Type, Application, End User, Blood Component, Material, Sales Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，血液處理拋棄式市場規模將達到 293.6 億美元，複合年成長率為 11.04%。

主要市場統計數據
基準年 2024 126.9億美元
預計年份：2025年 141億美元
預測年份：2032年 293.6億美元
複合年成長率 (%) 11.04%

一個權威的框架，闡述了影響醫療機構中一次性血液處理拋棄式產品的臨床、監管和供應鏈動態。

拋棄式產品市場處於臨床需求、生產精度和監管監督三者交匯點。血袋、離心機套件、採集套裝、過濾裝置和輸血套裝等設備對於包括血液採集、分離和輸血在內的眾多臨床環節至關重要。這些產品構成了血庫、診斷實驗室和醫院提供服務的基礎，形成了一個相互關聯的生態系統，對可靠性和可追溯性提出了極高的要求。

臨床自動化、材料創新、監管可追溯性和永續性壓力等多種因素正在重塑一次性用品的市場結構和供應商策略。

過去幾年，臨床實踐、供應鏈結構和創新模式發生了一系列變革性變化，這些變化共同重塑了血液處理拋棄式市場。首先，臨床工作流程越來越重視自動化和封閉式系統設計，以降低污染風險並簡化勞動密集任務。自動化離心套件和自動化分離技術因其能夠標準化輸出並提高處理量而備受關注。其次，從先進聚合物到改良阻隔膜，材料的創新使得設備具有更高的儲存穩定性和更強的生物相容性，為低溫運輸管理和敏感成分的長期儲存開闢了新的可能性。

從 2025 年開始的新關稅趨勢將迫使一次性產品和銷售管道的公司重新分配成本、轉移製造地並實現採購多元化。

2025年關稅表更新及貿易政策調整的實施，為在美國營運或從美國採購的製造商、經銷商和採購團隊帶來了許多複雜挑戰。關稅變化影響整個產品系列的到岸成本，包括初級和次級血袋、自動和手動離心機套件、採血套裝（包括配件和完整套裝）、過濾裝置（例如白血球去除過濾器和病原體去除過濾器）以及從定製到標準配置的各種輸血套裝。這些成本壓力會影響不同的市場管道，因為直銷團隊和第三方經銷商面臨的利潤率敏感度和合約限制各不相同。

細分市場層面的洞察揭示了產品差異、臨床應用、最終用戶、組件特定處理、材料和銷售管道如何決定商業性和監管方面的優先事項。

細緻的細分方法揭示了產品、應用、最終用戶、血液成分、材料和銷售管道等各個維度上的差異化價值促進因素和營運需求。在產品層面，血袋及其主要和輔助配置與離心套件有所區別，後者提供自動化和手動兩種形式。採血套裝涵蓋從配件到完整解決方案的各種產品，過濾裝置根據白血球去除和病原體去除功能進行區分，輸血套裝則從客製化解決方案到標準化產品進行分類。應用層面的細分區分了採血工作流程和分離輸血工作流程。分離過程本身又分為自動化和手動兩種，每種方式所需的設備、人員配備和品管要求各不相同。

臨床應用、監管複雜性和生產重點方面的區域差異，要求在美洲、歐洲、中東、非洲和亞太地區制定量身定做的市場進入策略。

區域特徵對美洲、歐洲、中東和非洲以及亞太地區的創新採納、監管時間表和採購行為有顯著影響。在美洲，集中式血庫網路和一體化醫院系統催生了對可擴展、高通量一次性系統的需求，促使供應商投資快速物流和本地認證。同時，在歐洲、中東和非洲地區，不同的管理體制和採購模式使得遵守各種標準、在地化標籤以及與當地經銷商夥伴關係對於市場准入和持續推廣至關重要。

在競爭激烈的環境中，能夠提供可靠性和臨床價值的整合解決方案提供者、技術專家和本地化響應型製造商將更具優勢。

血液處理拋棄式領域的競爭格局呈現出多元化的格局，既有產品系列豐富的全球領導企業，也有專注於先進過濾和自動化分離技術的利基企業，還有利用本地拋棄式和分銷網路的區域性參與企業。主要企業強調提供整合解決方案，將與耗材相容的設備、品管系統和服務結合，從而建立客戶層面的長期合作關係。而專業企業則透過專有的過濾介質、先進的聚合物配方或一次性自動化模組來應對特定的臨床挑戰，例如提高白血球去除效率或病原體減少，從而實現差異化競爭。

為取得競爭優勢，可採取切實可行的策略步驟，整合產品模組化、採購彈性、自動化、通路平衡與永續性。

產業領導者應採取多維策略，將產品開發、供應鏈韌性和商業性執行與不斷變化的臨床需求和市場現實相協調。首先，應優先考慮模組化和可擴展的產品設計，以便在主採血袋和衛星採血袋、自動和手動離心套件、配件和全套採血設備以及白血球去除和病原體去除過濾裝置之間快速重新配置。這種設計靈活性可縮短針對不同地區的產品上市時間，並提高對臨床醫師回饋的應對力。

透明的混合方法研究過程，結合技術審查和相關人員訪談，以穩健的三角驗證檢驗營運和商業見解。

我們的研究途徑結合了對技術文獻、監管申報文件和已發布的臨床指南的系統性回顧，以及定性的初步研究，以檢驗營運和商業方面的見解。二次分析著重於與血袋、離心機套件、採集套裝、過濾裝置和輸血套裝相關的設備規格、材料屬性資料和監管指南，以及影響採集、分離和輸血流程的政策。此外，我們還開展了一項初步調查計畫，包括對血庫採購人員、檢查室經理、負責輸血服務的臨床醫生以及生產和分銷機構的高管進行訪談，以獲得關於實施挑戰和促進因素的第一手資料。

概述產品差異化、採購彈性、法規遵循和區域專業化如何將技術進步轉化為臨床和營運價值。

總之，血液處理拋棄式產品領域正處於一個轉折點，臨床對安全性和效率的需求與供應鏈壓力以及不斷變化的監管要求交織在一起。產品層面的差異化——例如血袋、離心機套件、採血針、過濾裝置和輸血針——越來越體現在自動化能力、材料性能和地理市場進入等方面。從血庫到診斷實驗室再到醫院，終端使用者將優先選擇那些能夠證明其產品可降低污染風險、改善操作人體工學設計並在動態的價格和物流環境下提供可靠供應的供應商。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 用於血袋庫存和儲存管理的整合式數位追蹤系統
  • 開發封閉式採血裝置以最大限度降低污染風險
  • 引入病原體減少一次性試劑盒以提高血液製品的安全性
  • 提高輸血中心對即用型一次性白血球去除過濾器的偏好
  • 用於快速床邊血液分析的微流體一次性試劑盒的進展
  • 監管重點在於一次性血液管路組件的滅菌驗證。
  • 擴大在拋棄式產品製造中使用可生物分解和環保材料的範圍
  • 與醫療設備製造商和一家生物製藥公司合作，開發客製化的一次性血液分離器
  • 將具備RFID功能的耗材整合到一次性產品中，用於即時監測血液成分的使用情況。
  • 對冷凍乾燥血漿袋和一次性復溶試劑盒的需求激增

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依產品類型分類的血液處理拋棄式產品市場

  • 血袋
    • 主要包
    • 衛星套件
  • 離心試劑盒
    • 汽車套件
    • 手冊套件
  • 採血套裝
    • 配件套裝
    • 全套
  • 過濾裝置
    • 白血球去除過濾器
    • 病原體去除過濾器
  • 運輸套裝
    • 自訂套裝
    • 標準集

9. 按應用分類的血液處理拋棄式產品市場

  • 血液收集
  • 分離
    • 自動分離
    • 人工分離
  • 輸血

第10章 以最終用戶分類的血液處理拋棄式產品市場

  • 血庫
  • 診斷實驗室
  • 醫院

第11章 依血液成分分類的拋棄式產品市場

  • 電漿
    • 冷沉澱物
    • 新鮮冷沉澱物
  • 血小板
  • 紅血球
  • 全血

第12章 按材料分類的血液處理拋棄式產品市場

  • 聚丙烯
  • PVC
  • 矽

第13章 血液處理拋棄式產品市場（依銷售管道分類）

  • 直銷
  • 批發商

14. 各地區血液處理拋棄式產品市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 血液處理拋棄式產品市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

16. 各國血液處理拋棄式產品市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Terumo Corporation
    • Fresenius Kabi AG
    • Baxter International Inc.
    • Grifols SA
    • Haemonetics Corporation
    • Becton Dickinson and Company
    • Pall Corporation
    • Macopharma SA
    • Terumo BCT, Inc.
    • Cerus Corporation
Product Code: MRR-F97DD5A7E121

The Blood Processing Disposables Market is projected to grow by USD 29.36 billion at a CAGR of 11.04% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 12.69 billion
Estimated Year [2025] USD 14.10 billion
Forecast Year [2032] USD 29.36 billion
CAGR (%) 11.04%

An authoritative framing of clinical, regulatory, and supply chain dynamics that shape blood processing disposables across care settings

The blood processing disposables landscape sits at the intersection of clinical necessity, manufacturing precision, and regulatory scrutiny. Devices such as blood bags, centrifugation kits, collection sets, filtration devices, and transfer sets are integral to a wide spectrum of clinical pathways including collection, separation, and transfusion. In turn, these products underpin services delivered by blood banks, diagnostic laboratories, and hospitals, creating an interconnected ecosystem that demands high reliability and traceability.

Technological advances, evolving clinical protocols, and materials science improvements have steadily raised performance and safety standards. Simultaneously, supply chain dynamics and regulatory expectations have imposed new layers of complexity for manufacturers and procurement teams. Given the critical nature of blood handling, even incremental gains in device safety, handling ergonomics, or sterilization assurance translate into meaningful clinical and operational improvements. This introduction frames the fundamental dynamics that the subsequent sections unpack in greater technical and commercial detail.

Converging clinical automation, materials innovation, regulatory traceability, and sustainability pressures are reshaping the disposables landscape and supplier strategies

The last several years have witnessed transformative shifts across clinical practice, supply chain architecture, and innovation models that collectively redefine the blood processing disposables market. First, clinical workflows increasingly prioritize automation and closed-system designs to reduce contamination risk and streamline labor-intensive tasks; automated centrifugation kits and automated separation techniques are gaining attention for their capacity to standardize outputs and improve throughput. Second, materials innovation - from advanced polymers to improved barrier films - has enabled devices with longer shelf stability and enhanced biocompatibility, creating new possibilities for cold chain management and extended storage of sensitive components.

Concurrently, procurement strategies have evolved toward supplier consolidation and vendor-managed inventory to mitigate disruption risk and control cost. Regulatory authorities have raised expectations for post-market surveillance and traceability, prompting manufacturers to embed serialization and data capture capabilities into disposables. Finally, sustainability considerations are nudging design choices toward recyclable or lower-impact materials and processes, while also driving interest in devices that minimize waste through multi-functionality or modularity. Together, these shifts are realigning competitive positioning, investment priorities, and adoption timelines across the ecosystem.

New 2025 tariff dynamics are forcing cost reallocation, regional manufacturing shifts, and sourcing diversification across the full disposables product and channel spectrum

The introduction of updated tariff schedules and trade policy adjustments in 2025 has introduced tangible complexity for manufacturers, distributors, and procurement teams operating in or sourcing from the United States. Tariff changes affect landed costs across the product portfolio - blood bags including primary and satellite variants, centrifugation kits both automated and manual, collection sets whether accessory or complete, filtration devices such as leukocyte reduction and pathogen reduction filters, and transfer sets that range from custom to standard configurations. These cost pressures cascade differently depending on the route to market, as direct sales operations and third-party distributors each face distinct margin sensitivities and contractual constraints.

In response, supply chain managers and commercial leaders are recalibrating sourcing strategies, exploring regionalization of production, and negotiating longer-term contracts to stabilize input cost exposure. Some manufacturers are accelerating qualification of alternate suppliers for key materials like polypropylene, PVC, and silicone to diversify risk, while others are revisiting transfer pricing, inventory buffers, and logistics routing to optimize total landed costs. The tariff environment also amplifies the value of localized manufacturing capacity in the Americas and in other strategic regions, since proximity can reduce the tariff burden and improve service levels for end users such as blood banks, diagnostic laboratories, and hospitals. Ultimately, the interplay between tariffs, product complexity, and channel structure will determine which players can preserve competitiveness and which will need to adapt commercial models to maintain access to the US market.

Segment-level insights reveal how product variants, clinical applications, end users, component-specific handling, materials, and sales channels determine commercial and regulatory priorities

A nuanced segmentation approach reveals differentiated value drivers and operational requirements across product, application, end-user, blood component, material, and sales channel dimensions. Product-level distinctions separate Blood Bags and their primary and satellite configurations from Centrifugation Kits offered in automated and manual formats, while Collection Sets span accessory and complete solutions; Filtration Devices vary between leukocyte reduction and pathogen reduction capabilities, and Transfer Sets range from custom-engineered solutions to standardized offerings. Application segmentation distinguishes Collection from Separation and Transfusion workflows, with Separation itself bifurcated into automated and manual processes that have divergent equipment, staffing, and quality control implications.

End users include Blood Banks that emphasize throughput, traceability, and long-term storage compatibility; Diagnostic Laboratories that prioritize specimen integrity, chain-of-custody, and throughput for testing workflows; and Hospitals that require reliable, on-demand disposables for both routine and emergency transfusion pathways. Blood Component segmentation highlights plasma offerings such as cryoprecipitate and fresh frozen plasma, platelets, red blood cells, and whole blood, each with unique handling, filtration, and storage demands that influence product design and validation. Material choices - polypropylene, PVC, and silicone - drive compatibility with sterilization methods, shelf life, and regulatory filing strategies, while sales channels split between Direct and Distributor routes, shaping service models, contract terms, and post-sale support obligations. When viewed collectively, this segmentation underscores that product development, regulatory strategy, and commercial execution must be aligned to the specific clinical and operational contexts of target customers.

Regional variation in clinical adoption, regulatory complexity, and manufacturing priorities requires tailored market access strategies across the Americas, EMEA, and Asia-Pacific

Regional dynamics exert strong influence on innovation adoption, regulatory timelines, and procurement behavior across the Americas, Europe, Middle East & Africa, and Asia-Pacific regions. In the Americas, centralized blood bank networks and integrated hospital systems create demand for scalable, high-throughput disposable systems and incentivize suppliers to invest in quick-response logistics and domestic qualification. Conversely, Europe, the Middle East & Africa presents a mosaic of regulatory regimes and procurement models where conformity to diverse standards, localization of labeling, and regional distributor partnerships are critical to market access and sustained uptake.

Asia-Pacific is characterized by rapid capacity expansion, heterogeneous clinical infrastructure, and an accelerating push toward automation in higher-volume centers, which together create opportunities for both global incumbents and regional manufacturers. Transitioning between these regional realities requires suppliers to balance global product platforms with configurable localization, invest in region-specific clinical validation, and cultivate distributor or hospital system relationships that can bridge regulatory and logistical barriers. Moreover, cross-border trade considerations, tariff regimes, and local manufacturing incentives will continue to shape where and how suppliers prioritize capital allocation and commercial focus.

Competitive dynamics reward integrated solution providers, technical specialists, and regionally agile manufacturers that demonstrate reliability and clinical value

Competitive dynamics in the blood processing disposables sector are defined by a mix of global incumbents with broad product portfolios, specialized niche manufacturers focused on advanced filtration or automated separation technologies, and regional players who leverage localized production and distributor networks. Leading organizations emphasize integrated solutions that combine disposables with compatible instrumentation, quality management systems, and service offerings to lock in account-level relationships. Meanwhile, specialist firms differentiate through proprietary filtration media, advanced polymer formulations, or single-use automation modules that address specific clinical pain points such as leukocyte reduction efficiency or pathogen mitigation.

Strategic partnerships and M&A remain common approaches for scaling capabilities, accelerating market entry into new geographies, or complementing product portfolios with adjacent technologies. Companies that excel at regulatory harmonization, robust post-market surveillance, and rapid field support secure preferential status with high-volume blood banks and hospital systems. Additionally, investments in manufacturing flexibility, including configurable transfer sets and customizable collection set assemblies, allow suppliers to respond quickly to clinician preferences and procurement tenders. Collectively, the competitive landscape rewards technical differentiation, supply reliability, and the ability to demonstrate measurable clinical and operational benefits to end users.

Practical strategic steps for leaders to align product modularity, sourcing resilience, automation, channel balance, and sustainability to secure competitive advantage

Industry leaders should adopt a multi-dimensional strategy that aligns product development, supply chain resilience, and commercial execution with evolving clinical needs and trade realities. First, prioritize modular and scalable product designs that allow for rapid configuration between primary and satellite blood bags, automated and manual centrifugation kits, accessory and complete collection sets, and both leukocyte reduction and pathogen reduction filtration devices. This design flexibility reduces time-to-market for localized variants and improves responsiveness to clinician feedback.

Second, diversify material sourcing for critical polymers such as polypropylene, PVC, and silicone, and qualify alternate suppliers across multiple regions to reduce exposure to tariff-driven cost volatility. Third, invest in automation and closed-system workflows that support both automated and manual separation use cases, enabling end users to standardize procedures and improve traceability. Fourth, strengthen distributor relationships in complex regulatory regions while maintaining direct sales capabilities in high-volume systems to balance margin, control, and service requirements. Finally, incorporate sustainability targets into product roadmaps and packaging strategies to meet procurement criteria and public-sector tender priorities, while documenting lifecycle impacts to support procurement decisions.

A transparent mixed-methods research process combining technical review and stakeholder interviews to validate operational and commercial insights with robust triangulation

The research approach combined a structured review of technical literature, regulatory filings, and publicly available clinical guidance with qualitative primary research to validate operational and commercial insights. Secondary analysis focused on device specifications, material property data, and standards guidance relevant to blood bags, centrifugation kits, collection sets, filtration devices, and transfer sets, as well as policies that affect collection, separation, and transfusion workflows. To complement this, the primary research program included interviews with senior procurement leaders from blood banks, laboratory managers, clinicians overseeing transfusion services, and executives from manufacturer and distributor organizations to surface first-hand perspectives on pain points and adoption drivers.

Data validation employed triangulation across sources, cross-referencing product claims with regulatory summaries and clinician feedback to ensure practical relevance. Where possible, lifecycle and materials compatibility discussions were corroborated through technical white papers and manufacturer technical dossiers. The methodology emphasized transparency in assumptions, traceability of qualitative inputs, and iterative validation of emerging themes, ensuring that the conclusions reflect grounded, actionable observations rather than speculative projections.

Concluding synthesis of how product differentiation, sourcing resilience, regulatory alignment, and regional focus convert technical advances into clinical and operational value

In conclusion, the blood processing disposables domain is at an inflection point where clinical demand for safety and efficiency intersects with supply chain pressures and evolving regulatory expectations. Product-level differentiation across blood bags, centrifugation kits, collection sets, filtration devices, and transfer sets will increasingly be interpreted through the lenses of automation capability, materials performance, and regional market access. End users from blood banks to diagnostic laboratories and hospitals will favor suppliers that can demonstrably reduce contamination risk, improve handling ergonomics, and ensure reliable availability under shifting tariff and logistics conditions.

Forward-looking organizations that integrate design modularity, diversified sourcing, and strong post-market support will find themselves better positioned to capture operational partnerships with high-volume centers. At the same time, the ability to localize production and adapt to region-specific regulatory and procurement nuances will determine market entry success across the Americas, Europe, Middle East & Africa, and Asia-Pacific. These coordinated efforts will enable stakeholders to convert technical advancements into measurable clinical and operational value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of digital tracking systems for blood bag inventory and chain of custody management
  • 5.2. Development of closed system blood collection sets to minimize contamination risks
  • 5.3. Adoption of pathogen reduction disposable kits for improved blood product safety
  • 5.4. Growing preference for ready-to-use disposable leukoreduction filters in transfusion centers
  • 5.5. Advancements in microfluidic disposable cartridges for rapid bedside blood analysis
  • 5.6. Regulatory emphasis on sterilization validation of single-use blood tubing assemblies
  • 5.7. Expansion of biodegradable and ecofriendly materials in blood processing disposables manufacturing
  • 5.8. Collaboration between device makers and biopharma for bespoke disposable blood separators
  • 5.9. Integration of RFID-enabled disposables for real-time monitoring of blood component usage
  • 5.10. Surge in demand for freeze-dried plasma bags and single-use reconstitution kits

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Processing Disposables Market, by Product Type

  • 8.1. Blood Bags
    • 8.1.1. Primary Bags
    • 8.1.2. Satellite Bags
  • 8.2. Centrifugation Kits
    • 8.2.1. Automated Kits
    • 8.2.2. Manual Kits
  • 8.3. Collection Sets
    • 8.3.1. Accessory Sets
    • 8.3.2. Complete Sets
  • 8.4. Filtration Devices
    • 8.4.1. Leukocyte Reduction Filter
    • 8.4.2. Pathogen Reduction Filter
  • 8.5. Transfer Sets
    • 8.5.1. Custom Sets
    • 8.5.2. Standard Sets

9. Blood Processing Disposables Market, by Application

  • 9.1. Collection
  • 9.2. Separation
    • 9.2.1. Automated Separation
    • 9.2.2. Manual Separation
  • 9.3. Transfusion

10. Blood Processing Disposables Market, by End User

  • 10.1. Blood Bank
  • 10.2. Diagnostic Laboratory
  • 10.3. Hospital

11. Blood Processing Disposables Market, by Blood Component

  • 11.1. Plasma
    • 11.1.1. Cryoprecipitate
    • 11.1.2. Fresh Frozen Plasma
  • 11.2. Platelet
  • 11.3. Red Blood Cell
  • 11.4. Whole Blood

12. Blood Processing Disposables Market, by Material

  • 12.1. Polypropylene
  • 12.2. PVC
  • 12.3. Silicone

13. Blood Processing Disposables Market, by Sales Channel

  • 13.1. Direct
  • 13.2. Distributor

14. Blood Processing Disposables Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Blood Processing Disposables Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Blood Processing Disposables Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Terumo Corporation
    • 17.3.2. Fresenius Kabi AG
    • 17.3.3. Baxter International Inc.
    • 17.3.4. Grifols S.A.
    • 17.3.5. Haemonetics Corporation
    • 17.3.6. Becton Dickinson and Company
    • 17.3.7. Pall Corporation
    • 17.3.8. Macopharma SA
    • 17.3.9. Terumo BCT, Inc.
    • 17.3.10. Cerus Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. BLOOD PROCESSING DISPOSABLES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. BLOOD PROCESSING DISPOSABLES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BLOOD PROCESSING DISPOSABLES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRIMARY BAGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRIMARY BAGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRIMARY BAGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRIMARY BAGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRIMARY BAGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRIMARY BAGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SATELLITE BAGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SATELLITE BAGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SATELLITE BAGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SATELLITE BAGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SATELLITE BAGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SATELLITE BAGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY ACCESSORY SETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY ACCESSORY SETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY ACCESSORY SETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY ACCESSORY SETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY ACCESSORY SETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY ACCESSORY SETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COMPLETE SETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COMPLETE SETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COMPLETE SETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COMPLETE SETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COMPLETE SETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COMPLETE SETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PATHOGEN REDUCTION FILTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PATHOGEN REDUCTION FILTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PATHOGEN REDUCTION FILTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PATHOGEN REDUCTION FILTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PATHOGEN REDUCTION FILTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PATHOGEN REDUCTION FILTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CUSTOM SETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CUSTOM SETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CUSTOM SETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CUSTOM SETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CUSTOM SETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CUSTOM SETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY STANDARD SETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY STANDARD SETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY STANDARD SETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY STANDARD SETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY STANDARD SETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY STANDARD SETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED SEPARATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED SEPARATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED SEPARATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED SEPARATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED SEPARATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED SEPARATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL SEPARATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL SEPARATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL SEPARATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL SEPARATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL SEPARATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL SEPARATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BANK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BANK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BANK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BANK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BANK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BANK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CRYOPRECIPITATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CRYOPRECIPITATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CRYOPRECIPITATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CRYOPRECIPITATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CRYOPRECIPITATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CRYOPRECIPITATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FRESH FROZEN PLASMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FRESH FROZEN PLASMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FRESH FROZEN PLASMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FRESH FROZEN PLASMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FRESH FROZEN PLASMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FRESH FROZEN PLASMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLATELET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLATELET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLATELET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLATELET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLATELET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLATELET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY RED BLOOD CELL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY RED BLOOD CELL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY RED BLOOD CELL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY RED BLOOD CELL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY RED BLOOD CELL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY RED BLOOD CELL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PVC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PVC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PVC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PVC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PVC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PVC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SILICONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SILICONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SILICONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SILICONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SILICONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIRECT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIRECT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIRECT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIRECT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIRECT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIRECT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2018-2024 (USD MILLION)
  • TABLE 270. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2025-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, 2018-2024 (USD MILLION)
  • TABLE 272. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, 2025-2032 (USD MILLION)
  • TABLE 275. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 276. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 277. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, 2018-2024 (USD MILLION)
  • TABLE 278. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, 2025-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 280. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 281. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, 2018-2024 (USD MILLION)
  • TABLE 282. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 293. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2018-2024 (USD MILLION)
  • TABLE 298. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2025-2032 (USD MILLION)
  • TABLE 299. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, 2018-2024 (USD MILLION)
  • TABLE 300. LAT